- Location
drug therapy
"-
High Fibre Diet Could Rid Allergies, Monash University Study
Jun 23, 2016Most would not think that a diet lacking in fibre might be the cause of allergies, but success from Monash University have found evidence supporting this linkage. Studying allergies, scientists at Monash University in Melbourne discovered ...
Tags: fibre, allergies, immune system
-
Biosense Webster Receinves Approval From FDA for Thermocool Smarttouch Catheter
Feb 27, 2014Biosense Webster has obtained an approval from the US Food and Drug Administration (FDA) for its Thermocool Smarttouch catheter that enables direct and real-time measurement of contact force during catheter ablation procedures for patients ...
Tags: FDA Approval, Biosense Webster
-
ASA Released Its Second List of Five Targeted, Evidence-Based Recommendations
Jan 22, 2014Not prescribing opioids first or as a long-term therapy for chronic, non-cancer pain and avoiding MRIs, CTs and X-rays for low-back pain are among the tests and treatments identified by ASA that are commonly ordered but not always ...
-
FDA Approved Mekinist, or Trametinib, in Combination with Tafinlar
Jan 10, 2014The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...
Tags: Skin Cancer, Health, Medicine
-
Two Drugs Might Be Better Than One When It Comes to Helping Hardcore Smokers Quit
Jan 9, 2014Two drugs in combination might be better than one when it comes to helping hardcore smokers quit, at least in the short term, a new study suggests. The drugs -- varenicline (sold under the brand name Chantix) and bupropion (Wellbutrin) ...
Tags: a
-
The Study Authors Looked at The Efficacy of Combining The Medications Varenicline
Jan 9, 2014Among cigarette smokers, combining the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in higher smoking abstinence rates for one outcome but not the other at three and six months; rates ...
Tags: cigarette smokers, smoking cessation, varenicline, bupropion
-
Women Fighting an Aggressive Form of Breast Cancer May Benefit From Adding Certain Drugs
Dec 25, 2013Women fighting an aggressive form of breast cancer may benefit from adding certain drugs to their chemotherapy regimen, and taking them prior to surgery, new research finds. This pre-surgical drug therapy boosts the likelihood that no ...
-
A Compound in Fish Oil Appears to Leukemia Stem Cells and Could Lead to a Cure for Disease
Nov 19, 2013Scientists from the medical sciences division at Penn State University have discovered that a compound in fish oil appears to target leukemia stem cells and could lead to a cure for the disease. The compound is a natural extract from EPA, ...
-
US FDA Categorized Cepheid's Xpert Mtb/Rif Test
Aug 30, 2013The U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert MTB/RIF test as 'moderate complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF test is designed for the rapid molecular detection ...
Tags: moderate Complexity, Medicine
-
Cephid Received Market Authorization From The US FDA for MTB/Rif Test
Jul 26, 2013Cepheid, a California-based medical device firm, has received market authorization from the US Food & Drug Administration (FDA) for its Xpert MTB/RIF test, a tuberclosis test. The regulatory agency approved following a de novo 510(k) ...
Tags: Cephid, Tuberclosis Test
-
A Family of Giant Robots Behind The Scenes Counts and Processes Their Medications
May 14, 2013Posted by Jack Mans, Plant Operations Editor -- Packaging Digest, 5/11/2013 12:32:28 PM Although it won't be obvious to patients, a family of giant robots behind the scenes now counts and processes their medications. With a new automated ...
Tags: UCSF Robotic Pharmacy, Packaging
-
BioControl Medical's Third Phase Study of Its Cardiofit System Has Been Approved by FDA
Mar 29, 2013BioControl Medical has gained the US Food and Drug Administration approval to begin the third and largest phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical ...
Tags: BioControl Medical, FDA, Medical
-
Bioelectronics Pain Relief Therapy Delivery Devices Will Be Distributed by Alfa
Dec 18, 2012Alfa Medica, a supplier of medical equipments, has entered into an agreement to distribute BioElectronics' RecoveryRx postoperative and wound care therapy delivery device, ActiPatch musculoskeletal pain relief therapy and Allay menstrual ...
Tags: Alfa Medica, BioElectronics
-
BioControl Is Set to Commence INOVATE-HF The Second Phase Study
Dec 17, 2012BioControl Medical is set to commence the second phase of its INcrease Of VAgal TonE in Heart Failure (INOVATE-HF) study, following the US Food and Drug Administration (FDA) approval. The CardioFit system, which comprises a stimulator, a ...
Tags: BioControl Medical, INcrease Of VAgal TonE in Heart Failure study
-
ZEPHYRUS Enters Into an Agreement to Distribute BioElectronics' Recoveryrx Postoperative
Dec 17, 2012ZEPHYRUS, a company specialized in medical device sale, has entered into an agreement to distribute BioElectronics' RecoveryRx postoperative and wound care therapy delivery device, ActiPatch musculoskeletal pain relief therapy and Allay ...
Related Products
-
Medical Ultraosund Therapy Body Pain Reduction Physical Therapy Equipment
-
Ultrasound Drug Introduction Instrument Physical Ultrasound Therapeutic Machine Equipment for Pain Relief
-
Therapeutic Ultrasound Physiotherapy Rehabilitation Pain Relief Equipment
-
Multi-Function Medical Dressing Treatment Hospital Warehouse Trolleys
-
Hot Sale Hospital Furniture Nursing Medical Treatment Trolley
-
Hospital Furniture Emergency Medical Treatment Trolley with Silent Castors
